Indeed, in breast cancer (Kymionis et al, 2001; Sjostrom et al, 2002) and thyroid carcinoma (Viale et al, 1995), Bcl-2 positivity also showed a favourable outcome. Here, BCL2 is linked to thyroid gland carcinoma.